Open Menu Close Menu

For highly qualified investigator who hold an independent faculty-level appointment and is conducting original, independent applied research, often involving early-stage clinical trials that will advance the prevention, diagnosis or treatment of hematologic malignancies. Expected to have concomitant support for your research from another source or agency.